Global S1P Receptor Modulator Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4980085
- 89 Pages
- August 2022
- Pharmaceuticals
The United States S1P Receptor Modulator Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global S1P Receptor Modulator Drugs market, reaching US$ million by the year 2028. As for the Europe S1P Receptor Modulator Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main S1P Receptor Modulator Drugs players cover Novartis International AG, Bristol Myers Squibb, Pfizer Inc., and Sanofi SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of S1P Receptor Modulator Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Fingolimod
Ozanimod
Siponimod
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis International AG
Bristol Myers Squibb
Pfizer Inc.
Sanofi SA
Merck & Co., Inc.
Biogen Inc.
Roche Holding AG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global S1P Receptor Modulator Drugs Market Size 2017-2028
2.1.2 S1P Receptor Modulator Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 S1P Receptor Modulator Drugs Segment by Type
2.2.1 Fingolimod
2.2.2 Ozanimod
2.2.3 Siponimod
2.2.4 Others
2.3 S1P Receptor Modulator Drugs Market Size by Type
2.3.1 S1P Receptor Modulator Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
2.4 S1P Receptor Modulator Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 S1P Receptor Modulator Drugs Market Size by Application
2.5.1 S1P Receptor Modulator Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
3 S1P Receptor Modulator Drugs Market Size by Player
3.1 S1P Receptor Modulator Drugs Market Size Market Share by Players
3.1.1 Global S1P Receptor Modulator Drugs Revenue by Players (2020-2022)
3.1.2 Global S1P Receptor Modulator Drugs Revenue Market Share by Players (2020-2022)
3.2 Global S1P Receptor Modulator Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 S1P Receptor Modulator Drugs by Regions
4.1 S1P Receptor Modulator Drugs Market Size by Regions (2017-2022)
4.2 Americas S1P Receptor Modulator Drugs Market Size Growth (2017-2022)
4.3 APAC S1P Receptor Modulator Drugs Market Size Growth (2017-2022)
4.4 Europe S1P Receptor Modulator Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa S1P Receptor Modulator Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas S1P Receptor Modulator Drugs Market Size by Country (2017-2022)
5.2 Americas S1P Receptor Modulator Drugs Market Size by Type (2017-2022)
5.3 Americas S1P Receptor Modulator Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC S1P Receptor Modulator Drugs Market Size by Region (2017-2022)
6.2 APAC S1P Receptor Modulator Drugs Market Size by Type (2017-2022)
6.3 APAC S1P Receptor Modulator Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe S1P Receptor Modulator Drugs by Country (2017-2022)
7.2 Europe S1P Receptor Modulator Drugs Market Size by Type (2017-2022)
7.3 Europe S1P Receptor Modulator Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa S1P Receptor Modulator Drugs by Region (2017-2022)
8.2 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global S1P Receptor Modulator Drugs Market Forecast
10.1 Global S1P Receptor Modulator Drugs Forecast by Regions (2023-2028)
10.1.1 Global S1P Receptor Modulator Drugs Forecast by Regions (2023-2028)
10.1.2 Americas S1P Receptor Modulator Drugs Forecast
10.1.3 APAC S1P Receptor Modulator Drugs Forecast
10.1.4 Europe S1P Receptor Modulator Drugs Forecast
10.1.5 Middle East & Africa S1P Receptor Modulator Drugs Forecast
10.2 Americas S1P Receptor Modulator Drugs Forecast by Country (2023-2028)
10.2.1 United States S1P Receptor Modulator Drugs Market Forecast
10.2.2 Canada S1P Receptor Modulator Drugs Market Forecast
10.2.3 Mexico S1P Receptor Modulator Drugs Market Forecast
10.2.4 Brazil S1P Receptor Modulator Drugs Market Forecast
10.3 APAC S1P Receptor Modulator Drugs Forecast by Region (2023-2028)
10.3.1 China S1P Receptor Modulator Drugs Market Forecast
10.3.2 Japan S1P Receptor Modulator Drugs Market Forecast
10.3.3 Korea S1P Receptor Modulator Drugs Market Forecast
10.3.4 Southeast Asia S1P Receptor Modulator Drugs Market Forecast
10.3.5 India S1P Receptor Modulator Drugs Market Forecast
10.3.6 Australia S1P Receptor Modulator Drugs Market Forecast
10.4 Europe S1P Receptor Modulator Drugs Forecast by Country (2023-2028)
10.4.1 Germany S1P Receptor Modulator Drugs Market Forecast
10.4.2 France S1P Receptor Modulator Drugs Market Forecast
10.4.3 UK S1P Receptor Modulator Drugs Market Forecast
10.4.4 Italy S1P Receptor Modulator Drugs Market Forecast
10.4.5 Russia S1P Receptor Modulator Drugs Market Forecast
10.5 Middle East & Africa S1P Receptor Modulator Drugs Forecast by Region (2023-2028)
10.5.1 Egypt S1P Receptor Modulator Drugs Market Forecast
10.5.2 South Africa S1P Receptor Modulator Drugs Market Forecast
10.5.3 Israel S1P Receptor Modulator Drugs Market Forecast
10.5.4 Turkey S1P Receptor Modulator Drugs Market Forecast
10.5.5 GCC Countries S1P Receptor Modulator Drugs Market Forecast
10.6 Global S1P Receptor Modulator Drugs Forecast by Type (2023-2028)
10.7 Global S1P Receptor Modulator Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis International AG
11.1.1 Novartis International AG Company Information
11.1.2 Novartis International AG S1P Receptor Modulator Drugs Product Offered
11.1.3 Novartis International AG S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis International AG Main Business Overview
11.1.5 Novartis International AG Latest Developments
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Information
11.2.2 Bristol Myers Squibb S1P Receptor Modulator Drugs Product Offered
11.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bristol Myers Squibb Main Business Overview
11.2.5 Bristol Myers Squibb Latest Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. S1P Receptor Modulator Drugs Product Offered
11.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Inc. Main Business Overview
11.3.5 Pfizer Inc. Latest Developments
11.4 Sanofi SA
11.4.1 Sanofi SA Company Information
11.4.2 Sanofi SA S1P Receptor Modulator Drugs Product Offered
11.4.3 Sanofi SA S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sanofi SA Main Business Overview
11.4.5 Sanofi SA Latest Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Information
11.5.2 Merck & Co., Inc. S1P Receptor Modulator Drugs Product Offered
11.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck & Co., Inc. Main Business Overview
11.5.5 Merck & Co., Inc. Latest Developments
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Information
11.6.2 Biogen Inc. S1P Receptor Modulator Drugs Product Offered
11.6.3 Biogen Inc. S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Biogen Inc. Main Business Overview
11.6.5 Biogen Inc. Latest Developments
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Information
11.7.2 Roche Holding AG S1P Receptor Modulator Drugs Product Offered
11.7.3 Roche Holding AG S1P Receptor Modulator Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Roche Holding AG Main Business Overview
11.7.5 Roche Holding AG Latest Developments
12 Research Findings and Conclusion
Table 1. S1P Receptor Modulator Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Fingolimod
Table 3. Major Players of Ozanimod
Table 4. Major Players of Siponimod
Table 5. Major Players of Others
Table 6. S1P Receptor Modulator Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
Table 9. S1P Receptor Modulator Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global S1P Receptor Modulator Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global S1P Receptor Modulator Drugs Revenue Market Share by Player (2020-2022)
Table 14. S1P Receptor Modulator Drugs Key Players Head office and Products Offered
Table 15. S1P Receptor Modulator Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global S1P Receptor Modulator Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global S1P Receptor Modulator Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas S1P Receptor Modulator Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC S1P Receptor Modulator Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe S1P Receptor Modulator Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of S1P Receptor Modulator Drugs
Table 45. Key Market Challenges & Risks of S1P Receptor Modulator Drugs
Table 46. Key Industry Trends of S1P Receptor Modulator Drugs
Table 47. Global S1P Receptor Modulator Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global S1P Receptor Modulator Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global S1P Receptor Modulator Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global S1P Receptor Modulator Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global S1P Receptor Modulator Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global S1P Receptor Modulator Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. Novartis International AG Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 54. Novartis International AG S1P Receptor Modulator Drugs Product Offered
Table 55. Novartis International AG S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Novartis International AG Main Business
Table 57. Novartis International AG Latest Developments
Table 58. Bristol Myers Squibb Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 59. Bristol Myers Squibb S1P Receptor Modulator Drugs Product Offered
Table 60. Bristol Myers Squibb Main Business
Table 61. Bristol Myers Squibb S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Bristol Myers Squibb Latest Developments
Table 63. Pfizer Inc. Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 64. Pfizer Inc. S1P Receptor Modulator Drugs Product Offered
Table 65. Pfizer Inc. Main Business
Table 66. Pfizer Inc. S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Pfizer Inc. Latest Developments
Table 68. Sanofi SA Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 69. Sanofi SA S1P Receptor Modulator Drugs Product Offered
Table 70. Sanofi SA Main Business
Table 71. Sanofi SA S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Sanofi SA Latest Developments
Table 73. Merck & Co., Inc. Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 74. Merck & Co., Inc. S1P Receptor Modulator Drugs Product Offered
Table 75. Merck & Co., Inc. Main Business
Table 76. Merck & Co., Inc. S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Merck & Co., Inc. Latest Developments
Table 78. Biogen Inc. Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 79. Biogen Inc. S1P Receptor Modulator Drugs Product Offered
Table 80. Biogen Inc. Main Business
Table 81. Biogen Inc. S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Biogen Inc. Latest Developments
Table 83. Roche Holding AG Details, Company Type, S1P Receptor Modulator Drugs Area Served and Its Competitors
Table 84. Roche Holding AG S1P Receptor Modulator Drugs Product Offered
Table 85. Roche Holding AG Main Business
Table 86. Roche Holding AG S1P Receptor Modulator Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Roche Holding AG Latest Developments
List of Figures
Figure 1. S1P Receptor Modulator Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global S1P Receptor Modulator Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global S1P Receptor Modulator Drugs Market Size Market Share by Type in 2021
Figure 7. S1P Receptor Modulator Drugs in Hospital Pharmacies
Figure 8. Global S1P Receptor Modulator Drugs Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. S1P Receptor Modulator Drugs in Retail Pharmacies
Figure 10. Global S1P Receptor Modulator Drugs Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. S1P Receptor Modulator Drugs in Online Pharmacies
Figure 12. Global S1P Receptor Modulator Drugs Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. S1P Receptor Modulator Drugs in Others
Figure 14. Global S1P Receptor Modulator Drugs Market: Others (2017-2022) & ($ Millions)
Figure 15. Global S1P Receptor Modulator Drugs Market Size Market Share by Application in 2021
Figure 16. Global S1P Receptor Modulator Drugs Revenue Market Share by Player in 2021
Figure 17. Global S1P Receptor Modulator Drugs Market Size Market Share by Regions (2017-2022)
Figure 18. Americas S1P Receptor Modulator Drugs Market Size 2017-2022 ($ Millions)
Figure 19. APAC S1P Receptor Modulator Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Europe S1P Receptor Modulator Drugs Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa S1P Receptor Modulator Drugs Market Size 2017-2022 ($ Millions)
Figure 22. Americas S1P Receptor Modulator Drugs Value Market Share by Country in 2021
Figure 23. Americas S1P Receptor Modulator Drugs Consumption Market Share by Type in 2021
Figure 24. Americas S1P Receptor Modulator Drugs Market Size Market Share by Application in 2021
Figure 25. United States S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC S1P Receptor Modulator Drugs Market Size Market Share by Region in 2021
Figure 30. APAC S1P Receptor Modulator Drugs Market Size Market Share by Application in 2021
Figure 31. China S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. India S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe S1P Receptor Modulator Drugs Market Size Market Share by Country in 2021
Figure 38. Europe S1P Receptor Modulator Drugs Market Size Market Share by Type in 2021
Figure 39. Europe S1P Receptor Modulator Drugs Market Size Market Share by Application in 2021
Figure 40. Germany S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. France S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa S1P Receptor Modulator Drugs Market Size Market Share by Application in 2021
Figure 48. Egypt S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country S1P Receptor Modulator Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 54. APAC S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Europe S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 57. United States S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Canada S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Mexico S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Brazil S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 61. China S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Japan S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Korea S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 65. India S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Australia S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Germany S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 68. France S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 69. UK S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Italy S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Russia S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Spain S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Egypt S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 74. South Africa S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Israel S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Turkey S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries S1P Receptor Modulator Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
